| |
| |
|
| Insider
Information: |
Jenne Kyle |
| Relationship: |
Officer |
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,989 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$81,410 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,989 |
|
|
| Total
Value |
$81,410 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Akcea Therapeutics Inc |
AKCA |
Chief Commercial Officer |
2020-10-12 |
0 |
2019-10-21 |
0 |
Premium* |
|
|
Ionis Pharmaceuticals Inc |
IONS |
Officer |
2024-02-26 |
1,989 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
7 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chf GL Pdt Str OfcrOffice |
• – – |
2024-02-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,989 |
|
% |
|
| AKCA |
Akcea Therapeutics Inc |
Chief Commercial Officer |
• – – |
2020-10-12 |
4 |
D |
$18.15 |
$944,018 |
D/D |
(52,012) |
0 |
0 |
- |
|
| AKCA |
Akcea Therapeutics Inc |
Chief Commercial Officer |
• – – |
2020-09-22 |
4 |
S |
$18.12 |
$13,046 |
D/D |
(720) |
52,012 |
0 |
- |
|
| AKCA |
Akcea Therapeutics Inc |
Chief Commercial Officer |
• – – |
2020-03-23 |
4 |
S |
$11.75 |
$9,153 |
D/D |
(779) |
52,732 |
0 |
% |
|
| AKCA |
Akcea Therapeutics Inc |
Chief Commercial Officer |
• – – |
2020-03-19 |
4 |
A |
$0.00 |
$0 |
D/D |
16,800 |
53,511 |
0 |
- |
|
| AKCA |
Akcea Therapeutics Inc |
Chief Commercial Officer |
• – – |
2019-10-21 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
36,711 |
0 |
- |
|
| AKCA |
Akcea Therapeutics Inc |
Chief Commercial OfficerOffice |
• – – |
2019-10-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
11,711 |
|
- |
|
7 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
